Agenda Item 08 Enclosure KPCT/10/214
NHS KIRKLEES Report To:
PCT Trust Board
Nomination Policy v2 for Implementation of Release 2 of the Electronic prescription Service (EPS 2) with an Equality Impact Assessment.
FOI Exemption Category
Peter Flynn Director of Performance and Information
Author: Key Points to Note:
Lucianne Ricketts – Senior Medicines Management Advisor Chris Toothill – Community Pharmacy Governance Facilitator The NHS (Primary Medical Services) (Miscellaneous Amendments) Regulations 2005 and the NHS (Pharmaceutical Services) Regulations 2005 make provision for the introduction of nomination. Nomination is a new process that gives patients the option to choose, or ‘nominate’ dispensing contractor(s) to which their electronic prescription(s) can be sent automatically, using the Release 2 Electronic Prescription Service. Nomination could be likened to existing prescription collection services offered by some community pharmacies (particularly useful for repeat prescriptions), as it removes the need for patients to call at their GP practice to collect a paper prescription form. This nomination policy is required to ensure that ‘nomination’ takes place in a fair and equitable way across the health community and provides all stakeholders with information and clear localised protocols on how nomination will be managed and monitored by the PCT. It has been developed with due regard to the national guidance from Connecting For Health (CfH) and the Local Pharmaceutical Committee and Local Medical Committee have been consulted. The nomination policy is one of a number of required policies, procedures and other supporting elements which must be completed and approved by the PCT governance structure 1
before application to the Secretary of State for Statement of Directions to allow implementation of EPS2 in GP practices. NHS Kirklees submitted its application to the SHA for Cycle 3 of EPS2 national roll –out in November 2010. Approval of the original nomination policy was given by the PCT Board in Feb 2010 for a ten month period, pending production of an Equality Impact Assessment. This assessment is now complete and both the nomination policy and EIA are presented to the Board. Budget Implications:
Low – potential for conflict between dispensing contractors over nominations and patient dissatisfaction possible, arising from misunderstandings around nomination process.
Low – Departure from the nomination policy by contractors could lead to breach of contract proceedings being implemented by PCT.
• A more convenient service with a reduction in trips to the GP practice just to collect a paper prescription. This will benefit both patients and community pharmacies offering prescription collection services. • No need for GP practices to post prescriptions to dispensing appliance contractors - saving both time and resource. • The potential to reduce pharmacy waiting times, as dispensers will have the opportunity to prepare a prescription in advance of the patient arriving. • Greater freedom of choice for patients, making it simpler for them to use a dispensing contractor convenient to them (as opposed to one near their GP practice).
Minimal for PCT
See attached Equality Impact Assessment. Given that patients have the choice to either participate in nomination or remain within the traditional route of prescribing and dispensing it is concluded that there is no harmful impact.
Positive. Nomination has the potential to reduce carbon footprint as removes the necessity to collect paper prescriptions from GP practices and transport to Dispensing contractor. Reduction in printing and paper prescriptions gives additional environmental benefits.
Electronic Prescription Service release 2 Board and LHC/IMT Programme Board. The LMC and LPC have been consulted during the development of the policy.
The Board is asked to â€˘ Acknowledge and approve the Equality Impact Assessment produced for the nomination policy. â€˘ Ratify the nomination policy and approve its use across the PCT.